Tag Archives: HCR

Drug Reimbursement and the "New Medicaid"

By Guest Blogger | Published: August 9, 2012
by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there is little [...]
Posted in Guest Blog, Legal, Market Access, R&D, Regulatory, healthcare | Also tagged , , , , , , , | 1 Comment

IPAB : An HCR Acronym You Need to Understand

By Guest Blogger | Published: June 1, 2011
Tom Norton throws some light on the much-vaunted Independent Payment Advisory Board. Working towards our top issue for the June edition of the HCR Monthly Review, I continue to be struck by the amount of macroeconomic data that will be driving the new HCR law. Indeed, most of the key performance measures in the 2010 statute [...]
Posted in Regulatory, healthcare | Also tagged , , , , , | 2 Comments